Skip to main content
SpringerLink
Log in

Bladder cancer in Sweden

  • Papers
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The survival of patients with bladder cancer has not improved significantly during the past decades in spite of new diagnostic methods and treatment modalities. This observation underlines the need for improved routines to ensure earlier detection of the disease by patients and doctors and thereby start the treatment sooner. The common finding of treatment failures in patients who have shown no sign of local recurrence but have undergone radical cystectomy indicates that subclinical metastases are primarily responsible for the poor outcome in most cases. This indicates that, in addition to radical surgery, effective chemotherapy is needed to counteract the systemic spread of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Månsson, Å., Anderson, H. and Colleen, S. (1993) Time lag to diagnosis of bladder cancer -influence of psychosocial parameters and level of health-care provision.Scand. J. Urol. Nephrol. 27, 363–9.

    Article  PubMed  Google Scholar 

  2. Schröder, F.H., Cooper, E.H., Debruyne, F.MJ., Denis, L., Newling, D.W.W., Pavone-Macaluso, M., Smith, P.H., Sylvester, R. and Members of the EORTC Genitourinary Group. (1988) TNM classification of Genitourinary tumours 1987. Position of the EORTC Genitourinary Group.Br. J. Urol. 62, 502–10.

    Article  PubMed  Google Scholar 

  3. Hellsten, S., Malmström, P-U. and Månsson, W. (1995)State of the Art - Bladder cancer. Edited by the National Board of Health and Welfare.

  4. Rintala, E., Hannisdal, E., Fosså, S.D., Hellsten, S. and Sander S. (1993) Neoadjuvant chemotherapy in bladder cancer: A randomized study. Nordic Cystectomy Trial I.Scand. J. Urol. Nephrol. 27, 355–62.

    PubMed  CAS  Google Scholar 

  5. Steineck, G. and Scher, H.I. (1994) Integrated therapy for advanced bladder cancer.Current Opinion in Urology 4, 281–6.

    Article  Google Scholar 

  6. Skinner, D.G., Daniels, J.R., Russell, CA., Lieskovsky, G., Boyd, S.D., Nichols, P., Kern, W., Sakamoto, J., Krailo, M. and Groshen, S. (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.J. Urol. 145, 459–64.

    PubMed  CAS  Google Scholar 

  7. Crawford, E.D., Natale, R.B. and Burton, H. (1991) South-west Oncology Group Study (8710): Trial of cystectomy alone versus neoadjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080).Prog. Gin. Biol. Res. 353, 111–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Malmoe University Hospital, 205 02 Malmö and Research Group Clinical Epidemiology, CPE, Norrbacka S4, Karolinska Hospital, 171 76, Stockholm, Sweden

    Sverker Hellsten & Gunnar Steineck

Authors
  1. Sverker Hellsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunnar Steineck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hellsten, S., Steineck, G. Bladder cancer in Sweden. Med Oncol 14, 141–143 (1997). https://doi.org/10.1007/BF02989641

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02989641

Keywords

Search

Navigation